Zusammenfassung
Die bronchoalveoläre Lavage (BAL) bietet heute, neben einem hohen Sicherheitsprofil, eine Fülle von Befunden, die als diagnostische Marker eine Rolle spielen. Sie ist bei allen unklaren interstitiellen Lungenerkrankungen, auch bei solchen mit infektiöser Genese, zur diagnostischen Standarduntersuchung geworden. Bei relativ spezifischen Befunden wie der pulmonalen Alveolarproteinose, Langerhans-Zell-Histiozytose, der diffusen alveolären Blutung, diffusen malignen Infiltraten oder bei Staubexposition ist eine Lungenbiopsie meist nicht mehr erforderlich. Bei anderen Erkrankungen wie der Sarkoidose oder der exogen-allergischen Alveolitis kann bei entsprechender Klinik und radiologischem Befund das differenzialdiagnostische Spektrum stark eingeschränkt werden und auch in vielen Fällen die Diagnose ohne Biopsie gestellt werden. Bei der idiopathischen Lungenfibrose trägt die BAL zur Ausschlussdiagnostik, vor allem von Erkrankungen mit einer lymphozytären BAL, bei.
Abstract
Nowadays, bronchoalveolar lavage (BAL) offers a high safety profile and a wide range of findings which play a role as diagnostic markers. This has become the standard diagnostic procedure for all unclear interstitial lung diseases, even for those originating from infections. For relatively specific findings, such as pulmonary alveolar proteinosis, Langerhans cell histiocytosis, diffuse alveolar hemorrhaging, diffuse malignant infiltrates or exposure to dust, a pulmonary biopsy is no longer necessary. For other diseases such as sarcoidosis or extrinsic allergic alveolitis, a bronchoalveolar lavage can complement the corresponding clinical and radiological findings by limiting the differential diagnostic spectrum and in many cases the diagnosis can be made without a biopsy. In cases of idiopathic pulmonary fibrosis bronchoalveolar lavage can contribute to exclude other diagnoses, especially those with an increase of BAL lymphocytes.
Literatur
BAL Cooperative Group Steering Committee (1990) Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 141:169–202
Barrera L, Mendoza F, Zuñiga J et al (2008) Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med 177:44–55
Baughman RP, Drent M (2001) Role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med 22:331–341
Bouros D, Wells AU, Nicholson AG et al (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165:1581–1586
Chan TY, Hansell DM, Rubens MB et al (1997) Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans. Thorax 52:265–270
Costabel U (1994) Atlas der bronchoalveolären Lavage. Thieme, Stuttgart
Costabel U, Bross KJ, Matthys H (1985) Diagnosis by bronchoalveolar lavage of cause of pulmonary infiltrates in haematological malignancies. BMJ 290:1041
Costabel U, Guzman J (2001) Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 7:255–261
Costabel U, Guzman J (2003) Bronchoalveolar lavage. In: Gibson GJ, Geddes DM, Costabel U et al (eds) Respiratory Medicine. 3rd edn. Saunders, London, pp 438–448
Garcia JGN, Wolven RG, Garcia PL, Keogh BA (1986) Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases. Am Rev Respir Dis 133:444–449
Golde D, Drew L, Klein H et al (1975) Occult pulmonary hemorrhage in leukemia. BMJ 2:166–168
Greene NB, Solinger AM, Baughman RP (1987) Patients with collagen vascular disease and dyspnea. The value of gallium scanning and bronchoalveolar lavage in predicting response to steroid therapy and clinical outcome. Chest 91:698–703
Harbeck RJ (1998) Immunophenotyping of bronchoalveolar lavage lymphocytes. Clin Diagn Lab Immunol 5:271–277
Haslam PL, Baughman RP (1999) Report of ERS Task Force: Guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 14:245–248
Haslam PL, Baughman RP (1999) Report of European Respiratory Society (ERS) Task Force: guidelines for measurement of acellular components and recommmendations for standardization of bronchoalveolar lavage (BAL). Eur Respir Rev 9:25–157
Haslam PL, Dewar A, Butchers P et al (1987) Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases. Am Rev Respir Dis 135:35–47
Jamnig R, Sideroff G, Puelacher C et al (1991) Bronchoalveoläre Lavage und Tuberkulose: Vergleich zwischen Immunzytologie und Klinik. Mitt Öst Sanit Verwalt 92:253–254
Kahn F, Jones J, England D (1987) Diagnosis of pulmonary hemorrhage in the immunocompromised host. Am Rev Respir Dis 136:155–160
Klech H, Hutter C (1990) Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Force on BAL. Eur Respir J 3:937–974
Klech H, Pohl W (1989) Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the ERS Task Group. Eur Respir J 2:561–585
Lam S, Leriche JC, Kijek K, Phillips D (1985) Effect of bronchial lavage volume on cellular and protein recovery. Chest 88:856–859
Nagao T, Nagai S, Kitaichi M et al (2001) Usual interstitial pneumonia: idiopathic pulmonary fibrosis versus collagen vascular diseases. Respiration 68:151–159
Ohshimo S, Bonella F, Cui A et al (2009) Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179:1043–1047
Peterson MW, Nugent KM, Jolles H et al (1988) Uniformity of bronchoalveolar lavage in patients with sarcoidosis. Am Rev Respir Dis 137:719–784
Ryu YU, Chung MP, Han J et al (2007) Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med 101:655–660
Saito H, Anaissie EJ, Morice RC et al (1988) Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 94:745–750
Semenzato G, Poletti V (1992) Bronchoalveolar lavage in lung cancer. Respiration 59(Suppl 1):44–46
Teschler H, Konietzko N, Schoenfeld B et al (1993) Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage. Am Rev Respir Dis 147:1211–1215
Weynants P, Cordier JF, Chapuis Cellier C et al (1985) Primary immunocytoma of the lung: the diagnostic value of bronchoalveolar lavage. Thorax 40:542–543
Winterbauer RH, Lammert J, Selland M et al (1993) Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 104:252–261
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bauer, P., Bonella, F., Tötsch, M. et al. Die bronchoalveoläre Lavage aus klinischer Sicht. Pneumologe 6, 233–242 (2009). https://doi.org/10.1007/s10405-008-0304-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-008-0304-y
Schlüsselwörter
- Bronchoalveoläre Lavage
- Interstitielle Lungenerkrankungen
- Alveoläre Hämorrhagie
- Opportunistische Infektion
- Sarkoidose